Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001213900-20-014802
Filing Date
2020-06-12
Accepted
2020-06-12 15:00:14
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1865042
2 filename2.htm EX-10.7 17412
3 GRAPHIC logo_001.jpg GRAPHIC 58452
4 GRAPHIC logo_002.jpg GRAPHIC 4007
5 GRAPHIC image_001.jpg GRAPHIC 107488
6 GRAPHIC image_002.jpg GRAPHIC 98361
7 GRAPHIC image_003.jpg GRAPHIC 68729
8 GRAPHIC image_004.jpg GRAPHIC 50091
9 GRAPHIC image_005.jpg GRAPHIC 44882
10 GRAPHIC image_006.jpg GRAPHIC 54044
11 GRAPHIC image_007.jpg GRAPHIC 53914
12 GRAPHIC image_008.jpg GRAPHIC 72699
13 GRAPHIC image_009.jpg GRAPHIC 5154
14 GRAPHIC image_010.jpg GRAPHIC 4853
15 GRAPHIC image_011.jpg GRAPHIC 4285
16 GRAPHIC fimg_01.jpg GRAPHIC 11946
17 GRAPHIC ex10-7_001.jpg GRAPHIC 2849
  Complete submission text file 0001213900-20-014802.txt   2769345
Mailing Address 265 JINGJIU AVENUE JINGJIJISHU KAIFA DISTRICT, JINGGANGSHAN JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGJIJISHU KAIFA DISTRICT, JINGGANGSHAN JI'AN, JIANGXI F4 343100 86-0796-8404999
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: DRS/A | Act: 33 | File No.: 377-03139 | Film No.: 20959958
SIC: 2834 Pharmaceutical Preparations